ArticleNature immunology2019
Functional reprogramming of regulatory T cells in the absence of Foxp3.
Open access · greenAbstract read
In one paragraph
Article in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.
0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 138 citations in OpenAlex.
- Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis.European journal of immunology · 2026Article
- Glutamine-dependent biosynthetic pathways fuel autoreactive T and B cells in Foxp3 deficiency-mediated disease.JCI insight · 2026Article
- Deficiency of protein kinase Cδ reprograms macrophage immunometabolism to suppress pyroptosis and stabilize atherosclerotic plaques.Experimental & molecular medicine · 2026Article
- Immune tolerance platforms to mitigate unwanted immune responses.Journal of pharmaceutical sciences · 2026Review
- The Glucose Transporter GLUT3 Controls Regulatory T Cell Function.European journal of immunology · 2026Article
- Review
- Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant inJournal of human immunity · 2026Article
- Metabolic reprogramming of CAR-T cells: a multi-pronged strategy to conquer the immunosuppressive tumor microenvironment.Cell communication and signaling : CCS · 2026Review
- Targeting tumor-infiltrating regulatory T cells based on immunometabolism.Cancer biology & medicine · 2026Review
- Can we cure autoimmunity?Current opinion in immunology · 2026Review
- Review
- Mesenchymal Stem Cells Modulate Regulatory T Cells: From Molecular Mechanisms to Disease Therapy.Stem cells international · 2026Review
- Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects.Frontiers in immunology · 2026Review
- Tumor-immune metabolic tug-of-war: from immune escape to targeting metabolic rewiring in cancer therapy.Frontiers in cell and developmental biology · 2026Review
- Inborn errors of regulatory T-cell differentiation and function.The Journal of allergy and clinical immunology · 2025Review
- Elevated IL-17A-Secreting Regulatory T Cells in Sinonasal Tissues of Chronic Rhinosinusitis with Nasal Polyps.Inflammation · 2025Article
- Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.Experimental hematology & oncology · 2025Review
- Inducible protein degradation reveals inflammation-dependent function of the TScience immunology · 2025Article
- The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies.International journal of molecular sciences · 2025Review
- The 'TNature reviews. Rheumatology · 2025Review
34 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
13 authors at 7 institutions in 3 countries.
Louis-Marie CharbonnierDivision of Immunology, Boston Children's Hospital, Boston, MA, USA.
Ye CuiDivision of Immunology, Boston Children's Hospital, Boston, MA, USA.
Emmanuel Stephen-VictorDivision of Immunology, Boston Children's Hospital, Boston, MA, USA.
Hani HarbDivision of Immunology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8218-2538
David LopezDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA, USA.
Jack J BleesingDivision of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Maria I Garcia-LloretDivision of Allergy, Immunology, and Rheumatology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Karin ChenDivision of Allergy and Immunology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.
Ahmet OzenDivision of Pediatric Allergy and Immunology, Faculty of Medicine, Marmara University, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-9065-1901
Peter CarmelietLaboratory of Angiogenesis and Vascular Metabolism, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Matteo PellegriniDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9355-9564
Talal A ChatilaDivision of Immunology, Boston Children's Hospital, Boston, MA, USA. talal.chatila@childrens.harvard.edu.ORCID http://orcid.org/0000-0001-7439-2762
Boston Children's Hospital · USUniversity of California, Los Angeles · USCincinnati Children's Hospital Medical Center · USMarmara University · TRMemorial Sloan Kettering Cancer Center · USUniversity of Utah · USVIB-KU Leuven Center for Cancer Biology · BE
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MWomen's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5MSTRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4MMolecular Basis of Hyper lgE ImmunodeficiencyR01AI065617 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Talal Amine Chatila · 2006 to 2026
$10.9MNutrient Sensing and mTORC1 Signaling in the Control of Regulatory T Cell Generation and FunctionR01AI102888 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI LI, MING · 2014 to 2022
$4.3MMechanisms of Disease Pathogenesis in Regulatory T cell DeficiencyR01AI085090 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHATILA, TALAL AMINE, WILLIAMS, CALVIN B · 2010 to 2020
$3.9MNCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016042NIAID NIH HHS R01 AI065617NIAID NIH HHS R01 AI085090NIAID NIH HHS R01 AI102888NIDDK NIH HHS P30 DK034854
Abstract
Regulatory T cells (T
Indexed as
AnimalsCells, CulturedCellular ReprogrammingFemaleForkhead Transcription FactorsGene Expression RegulationGlycolysisHumansMaleMechanistic Target of Rapamycin Complex 2MiceMice, Inbred C57BLMice, KnockoutOxidative PhosphorylationRapamycin-Insensitive Companion of mTOR ProteinSignal TransductionForkhead Transcription FactorsFOXP3 protein, humanMechanistic Target of Rapamycin Complex 2Rapamycin-Insensitive Companion of mTOR Proteinrictor protein, mouse
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.